Start with the product’s own instructions
Ask the pharmacy to explain the name, form, storage directions and any detail you cannot read clearly. Compare its answers with the written plan from the prescriber.
The Food and Drug Administration, or FDA, has received reports of refrigerated weight-medicine injections arriving warm or without enough cooling.
GLP-1 medicines mimic a substance made in the body that helps manage blood sugar and hunger. Weight or diabetes care may use semaglutide products named Ozempic and Wegovy, or tirzepatide products named Mounjaro and Zepbound.
If a GLP-1 injection is warm on arrival or has not stayed cold enough, the FDA advises against using it because its quality may suffer.
Ask the pharmacy and prescriber to resolve any concern about the condition of that delivery.
Do not turn unclear directions into guesswork
The FDA has reported measurement mistakes with compounded semaglutide injections, including events that required hospital care.
A compounded medicine is one prepared to order. Ask its pharmacist to explain the instructions clearly, and leave calculations or changes to the care team.
The FDA also reports false pharmacy names on some compounded weight-medicine labels, as of September 26, 2026.
A label can therefore give you a name to check, but it does not complete the check.
Return to the pharmacy check